galactose has been researched along with apigenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Ding, H; Sang, Y; Wan, T; Wang, H; Xie, Y; Yang, K; Yao, J; Zhang, F; Zhou, Z | 1 |
| Chattopadhyay, D; Debnath, MC; Dewanjee, S; Ganguly, S; Gaonkar, R; Sen, R | 1 |
2 other study(ies) available for galactose and apigenin
| Article | Year |
|---|---|
Apigenin exhibits protective effects in a mouse model of d-galactose-induced aging via activating the Nrf2 pathway.
Topics: Aging; Animals; Antioxidants; Apigenin; Disease Models, Animal; Galactose; Humans; Male; Malondialdehyde; Mice; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase | 2017 |
Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma.
Topics: Animals; Apigenin; Carcinoma, Hepatocellular; Drug Carriers; Galactose; Liver Neoplasms; Nanoparticles; Particle Size; Rats | 2021 |